![]()  | 
![]()  | ![]()  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
    
     
    
    
 
    
    
    
OmniCorder Technologies (OMCT.ob) has a patented, FDA-approved device for advanced infrared diagnostics for use in medical imaging to detect cancer and vascular diseases.  Stock came public recently on December 19th through a reverse merger with Promos with OmniCorder becoming the successor company and recently raised about $8 million of private placement funding. The CEO is the brother of the head of the National Institute of Health (NIH). Caltech is a partial owner of the company. OMCT.ob has plans to leave the OTCBB and is chasing a potential $20 billion medical imaging market: winbmdo.com  | ||||||||||||||
 
        
 
  | 
    
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |